Stay updated on Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial page.

Latest updates to the Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial page
- Check7 days agoChange DetectedAdded Shanghai Municipality as a study location and updated the page to revision v3.3.3.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedThe page revision tag was updated from v3.2.0 to v3.3.2, representing a minor update to the page system. No study details, eligibility criteria, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page no longer shows a government funding status notice, while the trial details (title, conditions, interventions, eligibility, endpoints, contacts) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedNo significant changes detected in the core study content; the title, conditions, interventions, outcomes, eligibility criteria, enrollment, and locations appear unchanged, and the page layout remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check86 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing content and status information have changed.”}{SummaryDifference3%

- Check93 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0 and new contact/identifier details added (email, phone, and an ID).SummaryDifference0.1%

Stay in the know with updates to Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of Genolimzumab & Fruquintinib in Combo Clinical Trial page.